Doping dose of salbutamol and exercise: Deleterious effect on cancellous and cortical bones in adult rats

Journal of Applied Physiology

Volumn 102, Issue 4, 2007, Pages 1502-1509

  Bonnet, N ^a,c   Benhamou, C L ^a   Beaupied, H ^a   Laroche, N ^b   Vico, L ^b   Dolleans, E ^a   Courteix, D ^a  

^a UNIVERSITÉ D'ORLÉANS   (France)

^b UNIVERSITÉ JEAN MONNET   (France)

^c CENTRE HOSPITALIER RÉGIONAL D ORLÉANS   (France)

Author keywords

agonist; Architecture; Doping; Histomorphometry

Indexed keywords

DRUG VEHICLE; SALBUTAMOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE DENSITY; BONE MASS; BONE STRUCTURE; CANCELLOUS BONE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; CORTICAL BONE; DRUG EFFECT; DRUG MECHANISM; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FEMUR; MECHANICAL STRESS; NONHUMAN; PRIORITY JOURNAL; RAT; TIBIA; TREADMILL EXERCISE;

ADRENERGIC BETA-AGONISTS; ALBUTEROL; ANIMALS; BONE AND BONES; BONE DENSITY; DOPING IN SPORTS; EXERTION; FEMALE; PHYSICAL CONDITIONING, ANIMAL; RATS; RATS, WISTAR; TENSILE STRENGTH;

EID: 34147130887     PISSN: 87507587     EISSN: 15221601     Source Type: Journal    
DOI: 10.1152/japplphysiol.00815.2006     Document Type: Article

References (42)

1. Apseloff G, Girten B, Walker M, Shepard DR, Krecic ME, Stern LS, Gerber N. Aminohydroxybutane bisphosphonate and clenbuterol prevent bone changes and retard muscle atrophy, respectively, in tail-suspended rats. J Pharmacol Exp Ther 264: 1071-1078, 1993.
2. Arai M, Nagasawa T, Koshihara Y, Yamamoto S, Togari A. Effects of β-adrenergic agonists on bone-resorbing activity in human osteoclast-like cells. Biochim Biophys Acta 1640: 137-142, 2003.
3. Barengolts EI, Curry DJ, Bapna MS, Kukreja SC. Effects of endurance exercise on bone mass and mechanical properties in intact and ovariectomized rats. J Bone Miner Res 8: 937-942, 1993.
4. Barengolts EI, Curry DJ, Bapna MS, Kukreja SC. Effects of two non-endurance exercise protocols on established bone loss in ovariectomized adult rats. Calcif Tissue Int 52: 239-243, 1993.
5. 2-agonist treatment: bone mass, microarchitecture and strength analyses in female rats. Bone 37: 622-633, 2005.
6. 2-agonist treatment. Med Sci Sports Exerc 37: 1493-1501, 2005.
7. Caruso JF, Hamill JL, Yamauchi M, Cook TD, Mercado DR, Gibb G, Higginson BK, Elias J, Hernandez DA. Can albuterol help resistance exercise attenuate unloading-induced bone loss? J Strength Cond Res 18: 753-759, 2004.
8. Cavalie H, Lac G, Lebecque P, Chanteranne B, Davicco MJ, Barlet JP. Influence of clenbuterol on bone metabolism in exercised or sedentary rats. J Appl Physiol 93: 2034-2037, 2002.
9. Chappard DLE, Pascaretti C, Basle MF, Audran M. Comparison of eight histomorphometric methods for measuring trabecular bone architecture by image analysis on histological sections. Microsc Res Tech 45: 303-312, 1999.
10. Cleary BFR, Thompson H. Increasing adolescent anabolic steroid use: 5-year data (Abstract). Med Sci Sports Exerc 24: S45, 1992.
11. Currey JD. The many adaptations of bone. J Biomech 36: 1487-1495, 2003.
12. De Souza RL, Pitsillides AA, Lanyon LE, Skerry TM, Chenu C. Sympathetic nervous system does not mediate the load-induced cortical new bone formation. J Bone Miner Res 20: 2159-2168, 2005.
13. 2-agonists and risk of hip/femur fracture: a population-based case-control study. Pharmacoepidemiol Drug Saf. In press.
14. Frost H. Bone's mechanostat: a 2003 update. Anat Rec 275A: 1081-1101, 2003.
15. Frost HM, Schonau E. The "muscle-bone unit" in children and adolescents: a 2000 overview. J Pediatr Endocrinol Metab 13: 571-590, 2000.
16. Goldberg LED, MacKinnon DP, Moe E, Kuehl KS, Nohre L, Lockwood CM. Drug testing athletes to prevent substance abuse: background and pilot study results of the SATURN (Student Athlete Testing Using Random Notification) study. J Adolesc Health 32: 16 -25, 2003.
17. Hildebrand T, Ruegsegger P. A new method for the model-independent assessment of thickness in the three-dimensional images. J Microsc 185: 67-75, 1997.
18. Hogan HA, Ruhmann SP, Sampson HW. The mechanical properties of cancellous bone in the proximal tibia of ovariectomized rats. J Bone Miner Res 15: 284-292, 2000.
19. Iwamoto J, Shimamura C, Takeda T, Abe H, Ichimura S, Sato Y, Toyama Y. Effects of treadmill exercise on bone mass, bone metabolism, and calciotropic hormones in young growing rats. J Bone Miner Metab 22: 26-31, 2004.
20. 2-adrenergic receptors. Bone 22: 471-478, 1998.
21. Kitaura T, Tsunekawa N, Kraemer WJ. Inhibited longitudinal growth of bones in young male rats by clenbuterol. Med Sci Sports Exerc 34: 267-273, 2002.
22. Kondo A, Togari A. In vivo stimulation of sympathetic nervous system modulates osteoblastic activity in mouse calvaria. Am J Physiol Endocrinol Metab 285: E661-E667, 2003.
23. Libretto SE. A review of the toxicology of salbutamol (albuterol). Arch Toxicol 68: 213-216, 1994.
24. Lotinun S, Evans GL, Bronk JT, Bolander ME, Wronski TJ, Ritman EL, Turner RT. Continuous parathyroid hormone induces cortical porosity in the rat: effects on bone turnover and mechanical properties. J Bone Miner Res 19: 1165-1171, 2004.
25. McLaughlin F, Mackintosh J, Hayes BP, McLaren A, Uings IJ, Salmon P, Humphreys J, Meldrum E, Farrow SN. Glucocorticoid-induced osteopenia in the mouse as assessed by histomorphometry, microcomputed tomography, and biochemical markers. Bone 30: 924-930, 2002.
26. Muller R, Koller B, Hildebrand T, Laib A, Gianolini S, Ruegsegger P. Resolution dependency of microstructural properties of cancellous bone based on three-dimensional mu-tomography. Technol Health Care 4: 113-119, 1996.
27. Muller R, Van Campenhout H, Van Damme B, Van Der Perre G, Dequeker J, Hildebrand T, Ruegsegger P. Morphometric analysis of human bone biopsies: a quantitative structural comparison of histological sections and micro-computed tomography. Bone 23: 59 - 66, 1998.
28. Oxlund H, Dalstra M, Ejersted C, Andreassen TT. Parathyroid hormone induces formation of new cancellous bone with substantial mechanical strength at a site where it had disappeared in old rats. Eur J Endocrinol 146: 431-438, 2002.
29. Parfitt AM, Drezner MK, Glorieux FH, Kanis JA, Malluche H, Meunier PJ, Ott SM, Recker RR. Bone histomorphometry: standardization of nomenclature, symbols, and units. Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res 2: 595-610, 1987.
30. 2-agonists, formoterol and salbutamol on cancellous bone ovariectomized (ovx) rat (Abstract). Bone 9: A116, 1996.
31. Peng ZQ, Vaananen HK, Tuukkanen J. Ovariectomy-induced bone loss can be affected by different intensities of treadmill running exercise in rats. Calcif Tissue Int 60: 441-448, 1997.
32. Prather ID, Brown DE, North P, Wilson JR. Clenbuterol: a substitute for anabolic steroids? Med Sci Sports Exerc 27: 1118-1121, 1995.
33. Robling AG, Hinant FM, Burr DB, Turner CH. Improved bone structure and strength after long-term mechanical loading is greatest if loading is separated into short bouts. Bone Miner Res 17: 1545-1554, 2002.
34. Rutherford OM. Is there a role for exercise in the prevention of osteoporotic fractures? Br J Sports Med 33: 378-386, 1999.
35. Shackelford LCLA, Driscoll TB, Evans HJ, Rianon NJ, Smith SM, Spector E, Feeback DL, Lai D. Resistance exercise as a countermeasure to disuse-induced bone loss. J Appl Physiol 97: 119-129, 2004.
36. Takeda S, Elefteriou F, Levasseur R, Liu X, Zhao L, Parker KL, Armstrong D, Ducy P, Karsenty G. Leptin regulates bone formation via the sympathetic nervous system. Cell 111: 305-317, 2002.
37. Togari A. Adrenergic regulation of bone metabolism: possible involvement of sympathetic innervation of osteoblastic and osteoclastic cells. Microsc Res Tech 58: 77-84, 2002.
38. Turner CH, Burr DB. Basic biomechanical measurements of bone: a tutorial. Bone 14: 595-608, 1993.
39. Watanabe YOH, Mizuno K, Sekiguchi C, Fukunaga M, Kohri K, Rittweger J, Felsenberg D, Matsumoto T, Nakamura T. Intravenous pamidronate prevents femoral bone loss and renal stone formation during 90-day bed rest. J Bone Miner Res 19: 1771-1778, 2004.
40. Weiler JM, Ryan EJ 3rd. Asthma in United States Olympic athletes who participated in the 1998 Olympic Winter Games. J Allergy Clin Immunol 106: 267-271, 2000.
41. Yang YT, McElligott MA. Multiple actions of β-adrenergic agonists on skeletal muscle and adipose tissue. Biochem J 261: 1-10, 1989.
42. 2-receptor agonist, reduces net bone loss in denervated hindlimbs. Am J Physiol Endocrinol Metab 261: E285-E289, 1991.